InvestorsObserver
×
News Home

Will Iovance Biotherapeutics Inc (IOVA) Outperform the Rest of the Stocks in the Healthcare Sector?

Monday, March 18, 2024 12:52 PM | InvestorsObserver Analysts

Mentioned in this article

Will Iovance Biotherapeutics Inc (IOVA) Outperform the Rest of the Stocks in the Healthcare Sector?

Iovance Biotherapeutics Inc (IOVA) is near the top in its sector according to InvestorsObserver. IOVA gets an overall rating of 45. That means it scores higher than 45% of stocks. Iovance Biotherapeutics Inc gets a 92 rank in the Healthcare sector. Healthcare is number 2 out of 11 sectors.

Overall Score - 45
IOVA has an Overall Score of 45. Find out what this means to you and get the rest of the rankings on IOVA!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 45 would rank higher than 45 percent of all stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Iovance Biotherapeutics Inc Stock Today?

Iovance Biotherapeutics Inc (IOVA) stock is trading at $14.58 as of 12:41 PM on Monday, Mar 18, a rise of $0.66, or 4.78% from the previous closing price of $13.91. The stock has traded between $13.60 and $14.61 so far today. Volume today is less active than usual. So far 3,120,025 shares have traded compared to average volume of 13,576,134 shares. Click Here to get the full Stock Report for Iovance Biotherapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App